Tumor profiling tests may tailor cancer treatment
Studies show gene profiling could reveal which early lung cancer patients benefit from chemo and two breast cancer tests show similar accuracy. Duke led lung work with 133 gene fingerprint predicting recurrence with 93 percent accuracy in Duke samples and 75 percent overall. UNC Chapel Hill compared five tests and found four shared 80 percent accuracy, potentially enabling 30 to 50 percent of women to skip chemotherapy.
MENTIONED IN THIS ARTICLE
Len _Lichtenfeld
American Cancer Society
Lichtenfeld
New England Journal of Medicine
Duke University
Anil Potti
Rence
Duke
Potti
David Johnson
Vanderbilt University
American Society of Clinical Oncology
Johnson
University of North Carolina At Chapel Hill
Charles Perou
Joyce O’shaughnessy
Baylor Sammons Cancer Center
Alaska oil field shutdown prompts pipeline safety questions
The Prudhoe Bay shutdown after a small leak underscores concerns about corrosion and maintenance across U S pipelines. Alaska officials and industry leaders warn that aging systems require stronger oversight and repairs, potentially reducing national oil output for months.
MENTIONED IN THIS ARTICLE
Nchorage
Alaska
United States
Dan Lawn
Alaska Department of Environment Conservation
Alaska Forum For Environmental Responsibility
Stan Stephens
Prince William Sound
Stephens
BPPLC
Prudhoe Bay
Oil and Gas Industry
Scott Dean
BP PLC
Dean
West Virginia unveils rule on drug marketing disclosures
A new emergency rule in West Virginia requires pharmaceutical companies to disclose marketing and advertising spending to promote brand-name drugs. The measure, aimed at negotiating lower prescription prices, follows a dispute between House Speaker Kiss and Pharmaceutical Advocate Phares over the council’s authority to compel disclosures. Governor Manchin’s office plans talks to resolve the impasse while the council had previously dropped the requirement.
MENTIONED IN THIS ARTICLE
Charleston
West Virginia
Betty Ireland
Bob Kiss
D-Raleigh
Shana Phares
Kiss
Phares
Pharmaceutical Cost Management Council
Lara Ramsburg
Joe Manchin
Ramsburg
Britain Allows Cancer Predisposition Screening in Embryos
The decision by Britain's fertility authority to permit embryo screening for genes linked to cancer marks a shift from testing for certain diseases to assessing susceptibilities. U S policy remains unregulated with decisions left to doctors and patients, prompting calls for a global standard and ethical debate on how far genetic screening should go.
MENTIONED IN THIS ARTICLE
London
Britain
U.S
United States
New England Journal of Medicine
Peter Braude
Department of Women’s Health
King’s College
Braude
George Annas
Department of Law, Bioethics and
Human
Boston University
Annas
Human Fertility and Embryology Authority
Tanmoy Mukherjee
Reproductive Medicine Associates of
New York
Gemma Wilkie
Also Mentioned on This Page
By Linda A. Johnson
Associated Press
Frank Murkowski
State Capitol
Juneau
Senate
Ben Stevens
Ranchorage
House
John Harris
R-Valdez
Chevrolet
Cadillac
John
Bluefield
Colechevy.com
Princeton
Kris Fortner
GMC
Ramey’s
Travis Jackson